Total planned funding: $539,118,820
Clear active filters
Namibia
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Namibia | $539,118,820 |
Organizational Types
NGO | $145,652,729 |
Private Contractor | $104,610,078 |
Host Country Government Agency | $83,598,683 |
Own Agency | $75,687,898 |
Unknown | $58,512,007 |
University | $39,968,437 |
Implementing Agency | $9,841,995 |
Parastatal | $8,690,478 |
FBO | $5,301,683 |
Other USG Agency | $4,631,074 |
Multi-lateral Agency | $2,623,758 |
Program Areas
Treatment | $133,851,847 |
Prevention | $118,225,436 |
Care | $111,138,311 |
Governance and Systems | $79,598,902 |
Management and Operations | $57,588,692 |
Testing | $38,715,632 |
Budget Codes
HTXS: Treatment: Adult Treatment | $107,887,447 |
HVMS: Management and Operations | $57,588,692 |
HKID: Care: Orphans and Vulnerable Children | $40,846,881 |
OHSS: Health Systems Strengthening | $39,196,037 |
HVCT: Testing: HIV Testing and Counseling | $38,715,632 |
HBHC: Care: Adult Care and Support | $37,471,990 |
HVOP: Sexual Prevention: Other Sexual Prevention | $31,858,084 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $31,650,823 |
HVSI: Strategic Information | $30,655,102 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $27,560,191 |
HVTB: Care: TB/HIV | $20,818,768 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $19,334,629 |
PDTX: Treatment: Pediatric Treatment | $14,814,477 |
PDCS: Care: Pediatric Care and Support | $12,000,672 |
HTXD: Treatment: ARV Drugs | $11,149,923 |
HLAB: Laboratory Infrastructure | $9,747,763 |
HMBL: Biomedical Prevention: Blood Safety | $4,517,678 |
HMIN: Biomedical Prevention: Injection Safety | $3,304,031 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Potentia Namibia:
$63,359,971
Countries/Regions
USG Aggregated Agencies:
$52,607,094
Countries/Regions
Not Available:
$51,907,920
Countries/Regions